Personal tools
You are here: Home / News / Universidade NOVA group establishes protocol with Pfizer

Universidade NOVA group establishes protocol with Pfizer

A recent collaboration protocol between NOVA and Pfizer will be reinforcing the areas of research and development, as well as education and literacy.

Universidade NOVA de Lisboa and the biopharmaceutical company Pfizer have signed, at the end of January 2021, a collaboration protocol in the areas of Research & Development, Postgraduate Education, and Education for Health and Literacy.

Aware of the relevance and impact of chronic diseases and infection, the Chronic Disease and Infection group, one of NOVA health's strategic areas, promoted this link between NOVA and Pfizer.

This group, co-coordinated by researcher Lígia Saraiva at ITQB NOVA, also promotes "Think Tanks" with the goal of developing cooperation mechanisms between the two entities.

With this partnership, NOVA reinforces its mission towards collaborative, responsible, and internationally relevant research, which prioritizes the resolution of problems that affect the population, namely in the area of chronic diseases and infection.


Document Actions